Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beigene | Shanghai | Salute | Ricerca medica e biotecnologica | 173,85 Mrd CN¥ | -0,3x | -1,77 | 190,69 CN¥ | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,3% Rialzo | Fai l’upgrade a Pro+ | |
WuXi AppTec | Shanghai | Salute | Ricerca medica e biotecnologica | 158,33 Mrd CN¥ | 18,5x | -1,3 | 55,36 CN¥ | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 21% Rialzo | Fai l’upgrade a Pro+ | |
Pharmaron Beijing | Shenzhen | Salute | Ricerca medica e biotecnologica | 40,55 Mrd CN¥ | 23,5x | 1,01 | 24,85 CN¥ | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,7% Rialzo | Fai l’upgrade a Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Salute | Ricerca medica e biotecnologica | 39,21 Mrd CN¥ | 44,2x | -0,71 | 49 CN¥ | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 27,1% Rialzo | Fai l’upgrade a Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Salute | Ricerca medica e biotecnologica | 30,75 Mrd CN¥ | 19,8x | 0,14 | 68,33 CN¥ | 1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,8% Rialzo | Fai l’upgrade a Pro+ | |
Dizal Jiangsu Pharmaceutical | Shanghai | Salute | Ricerca medica e biotecnologica | 17,37 Mrd CN¥ | -20,2x | -0,97 | 41,59 CN¥ | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 34,6% Rialzo | Fai l’upgrade a Pro+ | |
Sinocelltech Group | Shanghai | Salute | Ricerca medica e biotecnologica | 15,96 Mrd CN¥ | -662,8x | -6,64 | 35,84 CN¥ | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BGI Genomics | Shenzhen | Salute | Ricerca medica e biotecnologica | 14,83 Mrd CN¥ | -156x | 0,8 | 38,89 CN¥ | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
RemeGen | Shanghai | Salute | Ricerca medica e biotecnologica | 12,14 Mrd CN¥ | -5,5x | 0,46 | 27,86 CN¥ | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,3% Rialzo | Fai l’upgrade a Pro+ | |
InnoCare Pharma | Shanghai | Salute | Ricerca medica e biotecnologica | 10,93 Mrd CN¥ | -28,9x | -1,91 | 12,15 CN¥ | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Joinn Laboratories China | Shanghai | Salute | Ricerca medica e biotecnologica | 10,92 Mrd CN¥ | -16.150x | 16,08 CN¥ | 2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -6,4% Ribasso | Fai l’upgrade a Pro+ | ||
Bio-Thera Solutions | Shanghai | Salute | Ricerca medica e biotecnologica | 7,71 Mrd CN¥ | -20,6x | -0,54 | 18,63 CN¥ | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
InventisBio | Shanghai | Salute | Ricerca medica e biotecnologica | 7,57 Mrd CN¥ | -21,2x | 16,89 | 13,13 CN¥ | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,5% Rialzo | Fai l’upgrade a Pro+ | |
Sino Biological | Shenzhen | Salute | Ricerca medica e biotecnologica | 7,24 Mrd CN¥ | 54,5x | -1,42 | 59,50 CN¥ | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,6% Rialzo | Fai l’upgrade a Pro+ | |
Mabwell Shanghai Bioscience | Shanghai | Salute | Ricerca medica e biotecnologica | 6,24 Mrd CN¥ | -6,4x | 0,44 | 15,61 CN¥ | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
GemPharmatech | Shanghai | Salute | Ricerca medica e biotecnologica | 5,33 Mrd CN¥ | 38,4x | -3,59 | 13,06 CN¥ | -3,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,2% Rialzo | Fai l’upgrade a Pro+ | |
HitGen | Shanghai | Salute | Ricerca medica e biotecnologica | 4,89 Mrd CN¥ | 90,9x | 1,41 | 12,23 CN¥ | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 27% Rialzo | Fai l’upgrade a Pro+ | |
R G PharmaStudies | Shenzhen | Salute | Ricerca medica e biotecnologica | 4,55 Mrd CN¥ | 31,4x | -9,1 | 47,13 CN¥ | -1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,2% Rialzo | Fai l’upgrade a Pro+ | |
Bide Pharmatech | Shanghai | Salute | Ricerca medica e biotecnologica | 4,28 Mrd CN¥ | 54,2x | -0,91 | 48,48 CN¥ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,1% Rialzo | Fai l’upgrade a Pro+ | |
Shanghai Aladdin Biochemical Technology Co | Shanghai | Salute | Ricerca medica e biotecnologica | 4,19 Mrd CN¥ | 34x | 0,97 | 15,12 CN¥ | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -7,4% Ribasso | Fai l’upgrade a Pro+ | |
Beijing Sun Novo Pharmaceutical Research | Shanghai | Salute | Ricerca medica e biotecnologica | 3,91 Mrd CN¥ | 21,7x | 1,65 | 34,87 CN¥ | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Beijing Kawin Technology Shareholding Co | Shanghai | Salute | Ricerca medica e biotecnologica | 3,79 Mrd CN¥ | 26,6x | 0,69 | 22,65 CN¥ | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Jiangsu Asieris Pharmaceuticals | Shanghai | Salute | Ricerca medica e biotecnologica | 3,77 Mrd CN¥ | -9x | 0,55 | 6,72 CN¥ | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31% Rialzo | Fai l’upgrade a Pro+ | |
Hangzhou BioSincerity PharmaTech | Shenzhen | Salute | Ricerca medica e biotecnologica | 3,69 Mrd CN¥ | 21x | -1,15 | 34,06 CN¥ | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Shanghai Medicilon | Shanghai | Salute | Ricerca medica e biotecnologica | 3,67 Mrd CN¥ | -17,6x | 0,05 | 27,49 CN¥ | -1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
PharmaResources Shanghai | Shenzhen | Salute | Ricerca medica e biotecnologica | 3,55 Mrd CN¥ | 478,1x | -5,63 | 25,78 CN¥ | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Guangzhou Boji Medical & Biotech | Shenzhen | Salute | Ricerca medica e biotecnologica | 3,17 Mrd CN¥ | 71,4x | 1,49 | 8,34 CN¥ | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 40,8% Rialzo | Fai l’upgrade a Pro+ | |
Qingdao Vland Biotech | Shanghai | Salute | Ricerca medica e biotecnologica | 2,99 Mrd CN¥ | 45,5x | -11,41 | 11,81 CN¥ | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ChemPartner PharmaTech | Shenzhen | Salute | Ricerca medica e biotecnologica | 2,97 Mrd CN¥ | -3,2x | 0,07 | 5,98 CN¥ | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hinova Pharmaceuticals | Shanghai | Salute | Ricerca medica e biotecnologica | 2,83 Mrd CN¥ | -13,6x | -0,39 | 28,58 CN¥ | -1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Anhui Wanbang Pharmaceutical | Shenzhen | Salute | Ricerca medica e biotecnologica | 2,55 Mrd CN¥ | 23,4x | -0,99 | 38,20 CN¥ | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Xinjiang Baihuacun | Shanghai | Salute | Ricerca medica e biotecnologica | 2,51 Mrd CN¥ | 130,4x | 0,78 | 6,56 CN¥ | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |